Simpósios
Sábado (02/06)
14:20-16:50
I - “1ST RSC/SBQ SYMPOSIUM “CHEMISTRY AND INNOVATION—FROM SPIN-OUT TO MARKET”
Antonio Sálvio Mangrich (SBQ) -Coordenador
“SBQ/RSC relationship: importance of this symposium to promote the chemical sciences and technology innovation”
This symposium, “Chemistry and Innovation—from spin-out to market”, is part of the United Kingdom - Brazil Year of Science & Innovation, a result of joint initiatives by the British and the Brazilian governments who, in 2006, agreed a science, technology, and innovation action plan. The Brazilian chemical industry plays a leading role in the development of several economic activities and had a net sale of US$ 80.0 Billion in 2006. The Sociedade Brasileira de Química – Brazilian Chemical Society (SBQ) has great interest and feels very comfortable in helping to promote this symposium establishing the UK/Brazil research collaboration framework in chemical science and technology innovation.
Simon Campbell and Alejandra Palermo (RSC) –Coordenador
“Chemistry and innovation from spin-out to market.”
The chemicals industry is a major manufacturing sector in the UK with an annual turnover of $50bn, apositive balance of trade surplus of $10bn and direct and indirect employment totalling over 1.25m. Historically, this sector has been dominated by large international organisations, but over the past two decades there has been an explosion of small, chemical science based spin out companies which seek to transform academic research discoveries into commercial opportunities. This introduction will provide an overview of chemical science spin out activity in the UK together with a review of critical success factors. In addition, the support provided by the RSC for such fledging companies will be discussed, particularly the role of the RSC Industry and Technology Forum.
Christopher R. Lowe (Cambridge University)
“Encouraging entrepreneurship in an academic environment.”
The Cambridge high technology cluster is universally regarded as the jewel in the crown of the UK and is one of the best known in the world. The Institute of Biotechnology is the only part of the University of Cambridge dedicated solely to biotechnology and was founded to cross not only the traditional boundaries between scientific disciplines and form a bridge between pure science and technological applications, but also to integrate other teaching, training and business activities into na entrepreneurial culture that embraces interactions with industry and promotes a seamless transition for exploitable research to the marketplace.
David Tapolczay (GSK)
“Where will the future source of Innovation and wealth creation in Pharmaceutical research come from? A personal perspective: Opportunities for innovation and entrepreneurialism from academia and small companies.”
Dr Tapolczay’s talk will cover the pressures associated with productivity and return on investment in major pharmaceutical company R and D. He will address how relationships between academic groups and Entrepreneurial small companies will help sustain innovation and growth in the pharmaceutical sector. Opportunities for new science disciplines, in particular nanotechnology, and the importance of networks and the ability to respond to changing environments will be discussed.
Carol Boyer (Chemical Innovation Knowledge Transfer Network)
“Mechanisms available in the UK to facilitate academia/industry collaboration enable partnerships.”
The UK Government has established a framework of Knowledge Transfer Networks to facilitate the connection between Industry and Academia. Our role in Chemistry Innovation is to connect both Industry and Academia whilst simplifying the support provisions available from Government. These mechanisms are my day job and form what we believe to be a best practise in connecting supply and demand in Industry and Academia. A snapshot of our journey over the last twelve months will reveal tips and techniques of engagement.
W. Graham Richards (University of Oxford,)
“Commercialising Chemistry.”
The Chemistry Department at Oxford has contributed over £80 million to the University as a result of creating spin-out companies. Some 18 companies have been founded with five of these having IPOs to become public companies quoted on the London Stock Exchange. The way in which this hás happened and some of the lessons learned will be described as will the extension to other UK universities by IP Group Plc. [www.ipgroupplc.com]
II - “A QUÍMICA E A INOVAÇÃO NO BRASIL”
Eliezer J. Barreiro (UFRJ) – Coordenador
Heloisio Rodrigues (LIBBS)
Kurt Politzer (IQT)
Oswaldo Luiz Alves (UNICAMP)
Neste Simpósio serão tratados aspectos relevantes da inovação química e seu impacto na qualidade de vida das pessoas, seja de forma direta, através da otimização ou da criação de novos produtos ou de forma indireta, fruto da interdisciplinaridade das Ciências Químicas. Considerando que a inovação química têm domínios expandidos a cada conquista tecnológica moderna, não haveria maneira de tratá-la em toda sua amplitude no limite de espaço e tempo deste Simpósio. Desta forma, alguns pontos de vista mais pontuais sobre o impacto da inovação em setores químicos relevantes, sob a ótica da academia e da empresa serão abordados pelos palestrantes, fiéis às suas especialidades.
REALIZAÇÃO 
